KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Addus HomeCare (ADUS) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Addus HomeCare (ADUS) over the last 17 years, with Q3 2025 value amounting to $245.6 million.

  • Addus HomeCare's Cost of Revenue rose 2429.51% to $245.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $906.8 million, marking a year-over-year increase of 1810.12%. This contributed to the annual value of $779.6 million for FY2024, which is 845.93% up from last year.
  • As of Q3 2025, Addus HomeCare's Cost of Revenue stood at $245.6 million, which was up 2429.51% from $235.6 million recorded in Q2 2025.
  • In the past 5 years, Addus HomeCare's Cost of Revenue ranged from a high of $245.6 million in Q3 2025 and a low of $144.1 million during Q1 2021
  • In the last 5 years, Addus HomeCare's Cost of Revenue had a median value of $177.7 million in 2023 and averaged $181.9 million.
  • As far as peak fluctuations go, Addus HomeCare's Cost of Revenue skyrocketed by 637.39% in 2024, and later skyrocketed by 2429.51% in 2025.
  • Addus HomeCare's Cost of Revenue (Quarter) stood at $151.8 million in 2021, then increased by 10.82% to $168.3 million in 2022, then increased by 9.3% to $183.9 million in 2023, then grew by 6.37% to $195.7 million in 2024, then increased by 25.52% to $245.6 million in 2025.
  • Its last three reported values are $245.6 million in Q3 2025, $235.6 million for Q2 2025, and $230.0 million during Q1 2025.